Cariprazine and Dipyrone: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 16, 2026 · Source data updated Jul 16, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Dipyrone
No brand names on recordCariprazine
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Here's what's going on. Cariprazine (Vraylar) is broken down by a liver enzyme called CYP3A4, and that same enzyme also creates cariprazine's important active forms in your body. Dipyrone can speed up that enzyme, which may change how much active medicine you end up with.
The honest truth is that this exact combination hasn't been studied closely, so we can't say for sure whether your cariprazine would work better, worse, or the same. Because Vraylar treats serious mental health conditions, we don't want to risk it losing effect or acting unpredictably. Please don't stop or change anything on your own. Your care team can watch how you're doing and adjust things if needed.
Mechanism: Cariprazine is a CYP3A4 substrate; CYP3A4 also mediates formation and elimination of its active metabolites (DCAR and DDCAR). Dipyrone is a putative CYP3A4 inducer.
- Direction: Induction could alter parent and active-metabolite exposure, but because CYP3A4 both forms and clears these metabolites, the net PK effect is genuinely unclear.
- Magnitude/onset: Not quantified; onset unspecified.
- Evidence: Theoretical.
- Management: Combination not recommended per labeling. If used, monitor closely for loss of efficacy or unexpected changes in response; dose should be individualized by the care team.
What happens
Effects on the cariprazine exposure has not been evaluated and the net effect is unclear
Interaction Deep Dive
It is advised against giving cariprazine (which is metabolized by CYP3A4) together with a CYP3A4 inducer. The generation as well as the clearance of cariprazine's active metabolites depend on CYP3A4. How CYP3A4 inducers alter cariprazine exposure has not been studied, so the overall consequence remains uncertain1.
Why it happens (mechanism)
Induction of CYP3A4-mediated metabolism of cariprazine
How to manage this interaction
What your care team may do:
- The product labeling says this combination generally isn't recommended, so your prescriber may consider a different option.
- If both are needed, your team may monitor you more closely for any change in how well your cariprazine is working.
- Your cariprazine dose may need to be adjusted and individualized by your care team.
What you should do: Keep taking both exactly as prescribed unless your prescriber tells you otherwise. Let your pharmacist or doctor know you take both, and report any return of symptoms, side effects, or changes in how you feel.
Management is individual — confirm any change with your pharmacist or prescriber.
Common questions
Can I take Cariprazine and Dipyrone together?
Combining dipyrone with cariprazine (Vraylar) is not recommended because dipyrone may change how much active cariprazine you have, in a way that hasn't been studied. Don't change anything yourself; talk with your pharmacist or doctor. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Cariprazine and Dipyrone interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Cariprazine and Dipyrone interaction managed?
What your care team may do: The product labeling says this combination generally isn't recommended, so your prescriber may consider a different option. If both are needed, your team may monitor you more closely for any change in how well your cariprazine is working. Your cariprazine dose may need to be adjusted and individualized by your care team. What you should do: Keep taking both exactly as p… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
Questions for your pharmacist
- Does my dose of Cariprazine or Dipyrone need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (1)
- Product Information: VRAYLAR(R) oral capsules, cariprazine oral capsules. AbbVie Inc. (per FDA), North Chicago, IL, 2024. DailyMed
Keep reading about Dipyrone
Keep reading about Cariprazine
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist